Microphyt

operates a 5,000 m² flagship production facility in Baillargues, built under the EU-funded SCALE project, using its proprietary CAMARGUE tubular photobioreactor technology to produce high-value bioactive ingredients for food,…

Country
France
biorefinery eu
Coverage
CNEUUS
upstream-bioreactors
Regulatorsfdaefsaepa

Verifiable facts

FactValueSource
Capacityexceeding 100 tons of high-value ingredients per yearcordis.europa.eu · microphyt.eu · cbe.europa.eu
CertificationFSSC 22000, COSMOS-approved, and ENVOL certified since 2017cordis.europa.eu · microphyt.eu · bic-montpellier.com
Regulatory approvalBrainPhyt ingredient approved by the FDA in 2019 medium confidencecordis.europa.eu
Production site5,000 m² industrial-scale biorefinery in Baillargues, Francecordis.europa.eu · microphyt.eu · bic-montpellier.com · cbe.europa.eu
Revenue€715,229 in 2021; reported as $3M annually in other sources (2021-12-31) medium confidenceentreprises.lefigaro.fr

Independent sources: bic-montpellier.com · cbe.europa.eu · cordis.europa.eu · entreprises.lefigaro.fr

Technologies
NameClusterRisk
Photobioreactors (microalgae)upstream-bioreactorsMedium

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.